Effects of aldose reductase inhibitors on the progression of nerve damage.
Greene
D A
DA
Michigan Diabetes and Research Training Center, Ann Arbor 48109-0580.
Sima
A A
AA
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors*; D000818:Animals; D003929:Diabetic Neuropathies / Q000188:drug therapy* / Q000503:physiopathology; D004311:Double-Blind Method; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D048289:Imidazolidines; D009281:Naphthalenes / Q000627:therapeutic use*; D009416:Nerve Regeneration / Q000187:drug effects; D013497:Sural Nerve / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology
D007093:Imidazoles; D048289:Imidazolidines; D009281:Naphthalenes; C040550:tolrestat; D000449:Aldehyde Reductase; C026411:sorbinil